Pharma Mar SA (PHMMF) reports a 46% surge in royalty income and European approval for Zepzelca, but faces a sharp EBITDA drop due to non-recurring revenues.

As the pan-European STOXX Europe 600 Index recently experienced a decline, with defensive sectors like utilities and telecoms showing relative strength amid geopolitical tensions, investors are closely monitoring high-growth tech stocks that have the potential to outperform in such uncertain environments. In this context, identifying promising tech companies involves assessing their ability to innovate and adapt within evolving market conditions while maintaining strong financial health and...

The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index experiencing a decline amid geopolitical tensions and economic uncertainties, as seen in the downturns of major indexes like Germany’s DAX and France’s CAC 40. In this environment, identifying high-growth tech stocks such as Pexip Holding becomes crucial for investors seeking opportunities that can navigate these complexities by leveraging innovative technologies and robust business models to...